146
Participants
Start Date
March 31, 2003
Primary Completion Date
March 31, 2004
Study Completion Date
April 30, 2005
Afimoxifene (0.057%) in hydroalcoholic gel
Lead Sponsor
ASCEND Therapeutics
INDUSTRY